Apple’s AirPods Pro have now secured approval to function as hearing aids, marking a critical regulatory milestone after a prolonged battle. This decision allows the tech giant’s earbuds to serve as clinical-grade hearing aids, available over-the-counter for $249 in the US and £229 in the UK. This significantly undercuts the cost of traditional hearing aids.
This breakthrough follows the 2017 Over-the-Counter Hearing Aid Act, enforced by the FDA after an executive order from the Biden administration in 2022. Leveraging on-demand hearing tests through the iPhone’s health app, users can now generate an audiogram to program the AirPods Pro. This makes them an accessible choice for those with mild to moderate hearing impairment.
The FDA’s decision addresses long-standing demands for more affordable hearing solutions. It underscores the interaction between technology, regulation, and healthcare. This approval could democratize access to hearing aids, offering millions a cost-effective option that blends cutting-edge technology with practical healthcare needs.
For more details, visit the full article here.
